![(11BS)-4-羟基-2,6-二碘二萘并[2,1-D:1',2'-F][1,3,2]二氧杂磷杂环庚 4-氧化物 (11bS)-4-Hydroxy-2,6-diiododinaphtho[2,1-d:1',2'-f][1,3,2]dioxaphosphepine 4-oxide](https://img.nicebiochem.com/bw-crm-product%2Fyuanye.png?x-oss-process=image/resize,m_fixed,h_800,w_800)
(11BS)-4-羟基-2,6-二碘二萘并[2,1-D:1',2'-F][1,3,2]二氧杂磷杂环庚 4-氧化物 (11bS)-4-Hydroxy-2,6-diiododinaphtho[2,1-d:1',2'-f][1,3,2]dioxaphosphepine 4-oxide
-
(11BR)-4-羟基-2,6-二碘二萘并[2,1-D:1',2'-F][1,3,2]二氧杂磷杂环庚 4-氧化物 (11bR)-4-Hydroxy-2,6-diiododinaphtho[2,1-d:1',2'-f][1,3,2]dioxaphosphepine 4-oxide
V84160-1g | 1g
-
(11bR)-2,6-二-1-芘基-4-羟基-4-氧化物二萘并[2,1-d:1',2'-f][1,3,2]二氧磷杂环庚烯 (11bR)-2,6-Di-1-pyrenyl-4-hydroxy-4-oxide-dinaphtho[2,1-d:1',2'-f][1,3,2]dioxaphosphepin
CCHM705967 | 25mg
-
(11bS)-2,6-二(4-氯苯基)-4-羟基-4-氧化物-二萘并[2,1-d:1',2'-f][1,3,2]二氧磷杂七环 (11bS)-2,6-Bis(4-chlorophenyl)-4-hydroxy-4-oxide-dinaphtho[2,1-d:1',2'-f][1,3,2]dioxaphosphepin, 98% (99% ee)
ZMR-15-0372 | 50mg
-
(11bS)-2,6-二(4-氟苯基)-4-羟基二萘[2,1-d:1',2'-f][1,3,2]二氧膦-4-氧化物 (11bS)-2,6-Bis(4-fluorophenyl)-4-hydroxydinaphtho[2,1-d:1',2'-f][1,3,2]dioxaphosphepine 4-oxide
V27828-5g | 5g
-
(11bS)-2,6-二-1-芘基-4-羟基-4-氧化物-二萘并[2,1-d:1',2'-f][1,3,2]二氧磷杂七环 (11bS)-2,6-Di-1-pyrenyl-4-hydroxy-4-oxide-dinaphtho[2,1-d:1',2'-f][1,3,2]dioxaphosphepin, 98%, (99% ee)
ZMR-15-0365 | 50mg
-
(11bR)-4-羟基-2,6-双(全氟苯基)二萘并[2,1-d:1',2'-f][1,3,2]二氧杂磷杂环庚三烯 4-氧化物 (11bR)-4-Hydroxy-2,6-bis(perfluorophenyl)dinaphtho[2,1-d:1',2'-f][1,3,2]dioxaphosphepine 4-oxide
R099777-250mg | 250mg
-
(11bR)-4-羟基-2,6-双(全氟苯基)二萘并[2,1-d:1',2'-f][1,3,2]二氧杂磷杂环庚三烯 4-氧化物 (11bR)-4-Hydroxy-2,6-bis(perfluorophenyl)dinaphtho[2,1-d:1',2'-f][1,3,2]dioxaphosphepine 4-oxide
R099777-1g | 1g
分子式：C20H11I2O4P
分子量：600.08
储存条件：RT，避光，惰性气体
外观：
用途：
您正在浏览的产品：(11BS)-4-羟基-2,6-二碘二萘并[2,1-D:1',2'-F][1,3,2]二氧杂磷杂环庚 4-氧化物
本公司销售的所有产品仅供实验科研使用，不用于人体及临床诊断。